Indian firms may garner up to 50% of USFDA nod share in 2023
NEW DELHI: Indian companies are expected to secure a 48-50 percent share of approvals for new drugs from the US ...
NEW DELHI: Indian companies are expected to secure a 48-50 percent share of approvals for new drugs from the US ...
Blitz Bureau NEW DELHI: Late strikes by Luis Díaz and Michael Olise sealed Bayern's place in the semi-finals after beating...
Read moreDetails